Immunocytes as a Biocarrier to Delivery Therapeutic and Imaging Contrast Agents to Tumors

<table>Distinct fluorescent expressions of Dox or LP-Dox (red) in tumors at 24 h postinjection of THP-1-LP-Dox. DAPI (blue) was used for a counter staining. Calibration bar = 50 <svg height="9.6750002" id="M31" style="vertical-align:-2.29482pt" version="1.1" viewbox="0 0 9.6374998 9.6750002" width="9.6374998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,9.675)">
<g transform="translate(72,-64.26)">
<text transform="matrix(1,0,0,-1,-71.95,66.6)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝜇</tspan>
</text>
</g>
</g>
</svg>m.</table>

Journal of Nanomaterials

fig4

Figure 4

Figure 4: Immunocytes as a Biocarrier to Delivery Therapeutic and Imaging Contrast Agents to Tumors 